December 2015
Volume 27, No. 12 |
|
|
|
|
|
FOCUS
Rita Peters
Intellectual challenge, job security, and opportunity for advancement contribute to employee happiness, but the ultimate prize may be a satisfactory salary for bio/pharma employees in Europe.
/ read more /
|
|
Andrew Teasdale, Bruce D. Naumann, Gretchen Allison, Wendy Luo, Courtney M. Callis, Bryan K. Shipp, Laura Rutter, Christopher Seaman
The results of an industry workgroup’s examination of EMA’s guide on shared facilities are presented.
/ read more /
|
|
FORMULATION
Adeline Siew, PhD
The advantages of fixed-dose combinations are well recognized but their formulation and manufacture can be a challenge, Stefania Barzanti from IMA Active explains why.
/ read more /
|
|
|
PharmTech Europe December Issue
|
|
advertisement
 |
|
Agnes Shanley
Quality by design, in-vitro release testing, and modern analytical methods are improving understanding and control of these complex formulations. / read more /
|
|
|
PEER-REVIEWED RESEARCH
James Agalloco, James Akers
Microorganism lethality requirements for process validation must always be balanced with the need to protect product integrity and patient safety.
/ read more / |
|
|
DRUG DEVELOPMENT
Gordon Haines, Marcus Spreen
Investing in worker training is crucial to the success of a company. This article reviews the benefits of a robust training program in pharmaceutical bulk manufacturing.
/ read more /
|
|
|
REGULATORY WATCH
Sean Milmo
Finalizing GMP requirements and quality standards for the development, manufacture, and clinical testing of ATMPs in the EU is proving to be a complex task.
/ read more /
|
|
|
OUTSOURCING REVIEW
Jim Miller
CMO industry consolidation may be frustrated by a dearth of attractive assets.
/ read more / |
|
|
API SYNTHESIS & MANUFACTURING
Cynthia A. Challener
A strong API market is expected in 2016 despite fewer new drug approvals.
/ read more / |
|
|
TROUBLESHOOTING
Jennifer Markarian
Analytical methods and functional assays are used to compare molecules and relate characteristics to quality attributes for determining biosimilarity.
/ read more /
|
|
|
ASK THE EXPERT
Susan J. Schniepp and Andrew Harrison
Susan Schniepp and Andrew Harrison, both of Regulatory Compliance Associates, discuss how to write standard operating procedures that hold up to audits.
/ read more /
|
|
|
Webcasts
Sponsored by AMRI
Merger and acquisition (M&A) trends in the contract services and biopharma space are set to continue in the coming years. Although M&A at contract manufacturing organizations (CMOs) can be a stressful time for clients, customers should know that M&As offer various opportunities for continuous improvement and the service providers that go through M&A integration most frequently are likely to be among the best proponents of the process. Learn best practices in approaching integration planning. Find out why change management is vital during acquisitions and learn what you should be communicating during integrations and when you should be talking to the CMO.
Sponsored by Patheon
The biopharmaceutical industry has seen ever increasing innovation over the past five years. Most notably, there has been an increase adoption of high-throughput process development (HTPD) and single-use technologies. Join our webinar to learn effective strategies to match product quality attributes for a biosimilar product and reduce process development timelines.
Sponsored by Thermo Fisher Scientific
Peptide quantitative analysis requires workflows that deliver high levels of data quality while balancing the needs of sample throughput and regulatory compliance. Learn how advances in sample preparation can enable greater speed, reproducibility, and improved data quality.
more webcasts |
|
|
Events
19–20 January 2016 | London, United Kingdom
20–21 January 2016 | London, United Kingdom
10–11 February 2016 | Paris, France
more events |
|
|
|
|
|